SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Respiratory Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Braganza, G.
Right arrow Articles by Thomson, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braganza, G.
Right arrow Articles by Thomson, N. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Lung Diseases
*Smoking
Hazardous Substances DB
*THEOPHYLLINE
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reviews

Review: Treating patients with respiratory disease who smoke

Georgina Braganza

Department of Respiratory Medicine, Division of Immunology, Infection & Inflammation, University of Glasgow, Glasgow, UK

Rekha Chaudhuri

Department of Respiratory Medicine, Division of Immunology, Infection & Inflammation, University of Glasgow, Glasgow, UK

Neil C. Thomson

Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow & Gartnavel General Hospital, Glasgow G12 OYN, UK, n.c.thomson@clinmed. gla.ac.uk

The high prevalence of cigarette smoking in patients with respiratory disease puts them at risk of developing clinically important drug interactions. Cigarette smoking reduces the therapeutic response to certain drugs such as theophyllines through the induction of hepatic cytochrome P450 isoenzymes. Smokers with asthma and patients with COPD have reduced sensitivity to corticosteroids, possibly due to non-eosinophilic airway inflammation, altered glucocorticoid receptor activity or reduced histone deacetylase activity. Although all smokers should be encouraged to stop smoking, there is limited information on the influence of smoking cessation on the therapeutic and anti-inflammatory effects of a number of the drugs used in the treatment of respiratory disease.

Key Words: cigarette smoking • asthma • COPD • idiopathic pulmonary fibrosis • corticosteroids • leukotriene receptor antagonists • theophylline • antibiotics

Therapeutic Advances in Respiratory Disease, Vol. 2, No. 2, 95-107 (2008)
DOI: 10.1177/1753465808089697
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement